1888PressRelease.com
1888 PressRelease Home Sign In Sign Up Contact Us About Us Sitemap

Bio3 Research S.r.l. Company News Section

Bio3 Research S.r.l. Information
Federico Gardini
Bio3 Research s.r.l. is an Italian private company based in Milan, with a representative office located at the Bioindustry Park Canavese (Turin).
Bio3 Research develops IP generated in the Academy. Its principal target is HMGB1 related Cardiovascular disorders and use of HMGB1 and its fragments in Connective Tissue Regeneration.
Bio3 Research S.r.l. Press Release
16
MAR
Bio3 Research S.r.l., Milan – Italy, Has Been Granted By The Australian Patent Office A Patent In The Field Of HMGB1
Bio3 Research S.r.l., Milan – Italy, has been granted by the Australian Patent Office a patent in the field of cardiovascular diseases related to HMGB1 over-expression and for the use of HMGB1 protein in connective tissue regeneration

MILANO, Italy, March 15, 2007 – Bio3 Research S.r.l. announced today that the Australian Patent Office has granted the company the patent in the HMGB1 ...